Ligand
Ligand is a California-based biopharmaceutical company that provides services such as drug discovery and product formulation for the pharmaceutical industry.
Business Model:
Revenue: $267.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Ligand Information
Geographic Data
Address: 3911 Sorrento Valley Blvd
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$650M
Raised Total:$91M
Social
Metrics
2,674,160Website Global Rank
6,265Website Monthly Traffic
Twitter Followers
Description
Ligand is a California-based biopharmaceutical company that provides services such as drug discovery and product formulation for the pharmaceutical industry.
Contact Phone:
+18585507500
Contact Email:
Ligand went public on 12/2/1994 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/2/1994
Ticker Symbol:
LGND
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2019 | Dianomi Therapeutics | Corporate Round | 3M |
| 12/2018 | Palvella Therapeutics | Corporate Round | 10M |
| 5/2014 | Viking Therapeutics | Debt Financing | 2.5M |
| 5/2020 | Palvella Therapeutics | Series C | 0 |
| 5/2020 | Palvella Therapeutics | Series C | 0 |
| 2/2019 | Dianomi Therapeutics | Corporate Round | 0 |
| 12/2018 | Palvella Therapeutics | Corporate Round | 0 |
| 5/2014 | Viking Therapeutics | Debt Financing | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/1989 | Seed Round | 1 | - |
Venrock Venrock |
8/2014 | Post-IPO Debt | $225M | 5/2018 | Post-IPO Debt | $650M | 1/2016 | Equity | $85.4M | 3/2016 | Debt | $6M |
Spectrum Pharmaceuticals |
1/1989 | Seed Round | 1 | - |
Venrock Venrock |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2020 | xCella Biosciences | |
| 9/2020 | Taurus Biosciences | |
| 8/2020 | Pfenex | |
| 2/2020 | Icagen - Core Assets, Partnered Programs And ION Channel Technologies | |
| 7/2019 | Ab Initio Biotherapeutics | |
| 8/2018 | Vernalis | |
| 10/2017 | Crystal Bioscience | |
| 12/2015 | OMT | |
| 5/2015 | Selexis | |
| 1/2011 | CyDex Pharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
